| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/23/2009 | WO2009071678A3 Morpholine derivatives as antiobesity agents |
| 07/23/2009 | WO2009071095A3 Prevention of hyperthermia subsequent to hypothermia treatment of ischemia |
| 07/23/2009 | WO2009070331A3 Compounds and methods for the selective inhibition of abcb1, abcc1 and abcg2 transporters and the treatment of cancers, especially drug resistant cancers and high throughput flow cytometry assay to detect selective inhibitors |
| 07/23/2009 | WO2009068906A3 Combinations comprising zd4054 and a src family kinase inhibitor 172 |
| 07/23/2009 | WO2009067690A3 Methods for safe and effective treatment using oxazaphosphorine drugs |
| 07/23/2009 | WO2009067182A3 Phospholipid compositions and uses thereof |
| 07/23/2009 | WO2009066182A3 Method of treating cancer |
| 07/23/2009 | WO2009066008A4 Novel beta-hydroxyketones and beta-alkoxyketones with estrogenic activity |
| 07/23/2009 | WO2009065130A3 Modified release formulations of diltiazem |
| 07/23/2009 | WO2009065028A3 Brca1-based breast or ovarian cancer prevention agents and methods of use |
| 07/23/2009 | WO2009064422A9 Hepatocyte growth factor pathway activators in fibrotic connective tissue diseases |
| 07/23/2009 | WO2009064374A8 Oral formulations of bis(thiohydrazide amides) |
| 07/23/2009 | WO2009063070A3 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 07/23/2009 | WO2009063061A3 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 07/23/2009 | WO2009062576A3 Benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same |
| 07/23/2009 | WO2009061889A3 Grape polyphenolics for platelet and bacterial control |
| 07/23/2009 | WO2009061431A3 Compositions for the treatment and prevention of eyelid swelling comprising an osmotically active ingredient and a vasoconstrictor |
| 07/23/2009 | WO2009055437A9 (1,4-diaza-bicyclo[3.2.2]non-6-en-4-yl)-heterocyclyl-methanone ligands for nicotinic acetylcholine receptors, useful for the treatment of disease |
| 07/23/2009 | WO2009055001A3 Methods of treating aging and methods of screening candidate agents therefor |
| 07/23/2009 | WO2009053794A3 The use of a monocyclic monoterpene in manufacturing medicaments for treatment of diabetes |
| 07/23/2009 | WO2009053742A3 Salts of nefopam and their use in therapy |
| 07/23/2009 | WO2009053549A8 Rimonabant dmso solvate, method for preparing same and pharmaceutical compositions containing same |
| 07/23/2009 | WO2009052379A3 Improved antitumoral treatments |
| 07/23/2009 | WO2009050352A3 Imidazolone derivatives, preparation method thereof and biological use of same |
| 07/23/2009 | WO2009045536A3 Receptor targeted oligonucleotides |
| 07/23/2009 | WO2009043747A3 N-heterocyclic biaryl carboxamides as ccr receptor antagonists |
| 07/23/2009 | WO2009042114A3 Phenazine derivatives and uses thereof |
| 07/23/2009 | WO2009038771A3 Tolperisone and tolperisone-like drugs for the treatment of k-ras associated cancers |
| 07/23/2009 | WO2009038759A3 1-(4-(benzylbenzamid0) -benzyl) azetidine-3-carboxylic acid derivatives and related compounds as slp receptor modulators for the treatment of immune disorders |
| 07/23/2009 | WO2009037262A3 Method of preventing early lawsonia intracellularis infections |
| 07/23/2009 | WO2009031023A3 Pomegranate extracts, nutritional products containing them and their uses |
| 07/23/2009 | WO2009027803A3 Polymorphs of (3-(((4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino)-methyl)- phenoxy)-acetic acid, free acid |
| 07/23/2009 | WO2009023664A3 Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1 |
| 07/23/2009 | WO2009020848A8 RNAI-RELATED INHIBITION OF TNFα SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA |
| 07/23/2009 | WO2009020847A3 Rnai-related inhibition of tnfa signaling pathway for treatment of ocular angiogenesis |
| 07/23/2009 | WO2009016520A3 Thiophosphi(o)nic acid derivatives and their use as agonists or antagonists for metabotropic glutamate receptors |
| 07/23/2009 | WO2009016358A3 Pharmaceutical compositions and process for making them |
| 07/23/2009 | WO2009015063A8 Methods and compositions for treating fibrosis related disorders using il-17 antagonists |
| 07/23/2009 | WO2009013348A3 Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions |
| 07/23/2009 | WO2009012734A3 New salts of bazedoxifene |
| 07/23/2009 | WO2009011912A8 A composition for treating hiv comprising virus-like particles |
| 07/23/2009 | WO2009005671A3 Substituted piperazines as cb1 antagonists |
| 07/23/2009 | WO2009005338A3 Solid forms ult-i, ult-2 and ult-3 of emtricitabine |
| 07/23/2009 | WO2009002808A3 Quinazolinone compounds and methods of use thereof |
| 07/23/2009 | WO2009001214A3 Thieno[2,3-d]pyrimidin-4(3h)-one, isoxazolo[5,4-d]pyrimidin-4(5h)-one and isothiazolo[5,4-d]pyrimidin-4(5h)-one derivatives as calcium receptor antagonists |
| 07/23/2009 | WO2009001085A3 An inhalable composition comprising nicotine |
| 07/23/2009 | WO2009000843A3 Treatment of heart failure in non-human animal mammals by an aldosterone antagonist |
| 07/23/2009 | WO2009000551A8 Use of a synergistic composition as a therapeutic agent or disinfectant |
| 07/23/2009 | WO2008156550A3 Treatment of pulmonary hypertension with carbonic anhydrase inhibitors in combination with a sympathomimetic amine |
| 07/23/2009 | WO2008155777A3 Process for preparing efletrizine |
| 07/23/2009 | WO2008151639A3 Oligonucleotides for modulation of target rna activity |
| 07/23/2009 | WO2008149154A3 Tegaserod succinate and polymorphic forms |
| 07/23/2009 | WO2008147640A3 Hormone replacement therapy |
| 07/23/2009 | WO2008142693A8 Regulation of myelination by nectin-like (necl) molecules |
| 07/23/2009 | WO2008136748A8 Tumour growth inhibitory compounds and methods of their use |
| 07/23/2009 | WO2008127591A3 Pyrimidinedione derivatives and use thereof |
| 07/23/2009 | WO2008125901A8 2-methylene-1alpha,25-dihydroxy-18,19,21-trinorvitamin d3 and uses thereof |
| 07/23/2009 | WO2008122439A3 Dr0spiren0ne/17beta-estradi0l regimen, pharmaceutical combination product and kit for performing this regimen |
| 07/23/2009 | WO2008119571A3 Nucleic acid myostatin antagonist aptamers obtained by (mirror- image) selex |
| 07/23/2009 | WO2008116601A3 Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof |
| 07/23/2009 | WO2008106689A3 Breakthrough pain management |
| 07/23/2009 | WO2008103351A3 Heterocyclic aspartyl protease inhibitors |
| 07/23/2009 | WO2008102037A8 Use of compounds as inhibitors for helicobacter flavodoxin |
| 07/23/2009 | WO2008096001A8 Hcv inhibiting macrocyclic phenylcarbamates |
| 07/23/2009 | WO2008087421A3 Male contraceptive |
| 07/23/2009 | WO2008084504A3 Pharmaceutical compositions of angiotensin ii receptor blockers |
| 07/23/2009 | WO2008084171A9 Use of nepafenac or derivatives thereof for treating dermatological disorders linked with a keratinisation disorder that may include an inflammatory immuno-allergic component |
| 07/23/2009 | WO2008076427A3 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof |
| 07/23/2009 | WO2008061796A3 Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins |
| 07/23/2009 | WO2008059130A9 Thionucleosides and pharmaceutical applications |
| 07/23/2009 | WO2008056388A8 Drug based on ozonized terpenes or terpene-derivatives, processes for producing it and uses thereof |
| 07/23/2009 | WO2008055136A3 Liquid formulations of phospholipase enzyme inhibitors |
| 07/23/2009 | WO2008001369A8 Use of cb2 receptor agonists for promoting neurogenesis |
| 07/23/2009 | WO2007143146A3 Method of treating inflammatory diseases using tyroskine kinase inhibitors |
| 07/23/2009 | WO2007103876A8 Cancer therapeutic |
| 07/23/2009 | WO2007095387A8 Compositions and methods for inhibiting gene silencing by rna interference |
| 07/23/2009 | WO2006110240A3 Gene transfer with adenoviruses having modified fiber proteins |
| 07/23/2009 | US20090187025 Pharmaceutical composition for promoting angiogenesis |
| 07/23/2009 | US20090187023 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl))-piperidine-2,6-dione |
| 07/23/2009 | US20090187013 Synthetic heparin pentasaccharides |
| 07/23/2009 | US20090186951 Identification of novel pathways for drug development for lung disease |
| 07/23/2009 | US20090186950 13,13-Dimethyl-des-C,D Analogs of 1Alpha,25-Dihydroxy-19-Nor-Vitamin D3 Compounds and Topical Composition Dosage Forms and Methods of Treating Skin Conditions Thereof |
| 07/23/2009 | US20090186949 Method for Treating Endothelial and Epithelial Cell Disorders by Administering High Molecular Weight PEG-Like Compounds |
| 07/23/2009 | US20090186947 Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride |
| 07/23/2009 | US20090186946 Genetically Modified Animal and Use Thereof |
| 07/23/2009 | US20090186945 Abuse-resistant amphetamine prodrugs |
| 07/23/2009 | US20090186944 Prevention and treatment of breast cancer with 4-hydroxy tamoxifen |
| 07/23/2009 | US20090186943 Antiseptic Ointment |
| 07/23/2009 | US20090186942 Novel nutraceutical and pharmaceutical compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
| 07/23/2009 | US20090186940 Synthesis of Scabronines and Analogues Thereof |
| 07/23/2009 | US20090186939 Method of Treating Chronic Kidney Disease |
| 07/23/2009 | US20090186938 Antitumoral dihydropyran-2-one compounds |
| 07/23/2009 | US20090186937 Method for Treating Addiction Using Quercetin-Containing Compositions |
| 07/23/2009 | US20090186936 Tea beverages containing proanthocyanidins |
| 07/23/2009 | US20090186935 Taste titration therapies |
| 07/23/2009 | US20090186934 Beta Crystalline form of the Arginine Salt of Perindopril, a Process for its Preparation and Pharmaceutical Compositions Containing it. |
| 07/23/2009 | US20090186933 Indole, azaindole and related heterocyclic pyrrolidine derivatives |
| 07/23/2009 | US20090186931 Dinitropyrazole derivatives, their preparation, and energetic compositions comprising them |
| 07/23/2009 | US20090186930 Novel imidazole derivatives, preparation and user thereof as medicine |
| 07/23/2009 | US20090186929 Method and agent for inducing apoptosis/cell death in leukemia cells |